Minerva Neurosciences, Inc. — Director's Dealing 2016

Dec 29, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Minerva Neurosciences, Inc. (NERV)
CIK: 0001598646
Period of Report: 2016-12-27

Reporting Person: Ahlholm Frederick W (SVP, Chief Accounting Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-12-27	Common Stock	M	12000	$4.71	Acquired	22000	Direct
2016-12-27	Common Stock	S	17000	$12.51	Disposed	5000	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-12-27	Employee Stock Option (Right to Buy)	$4.71	M	12000	Disposed	2025-12-03	Common Stock (12000)	Direct

Footnotes

F1: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 22, 2016.

F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.20 - $13.00, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (2) to this Form 4.

F3: This option vested as to 25% of the shares on December 4, 2016 and then in quarterly installments over 3 years thereafter.